According to research presented at the First International Congress on Pre-Diabetes and Metabolic Syndrome, Barley beta-glucan.
In the six-week study, 76 men and 79 women with hypercholesterolemia, aged
25 to 73, completed a four-week low-fat diet prior to baseline.
At the beginning of the trial, test subjects were randomly allocated to one of four treatment groups or a control group and assayed for blood lipids and other cardiovascular disease (CVD) biomarkers.
During the course of the study, test groups were administered 3 g and 5 g doses of low molecular weight (LMW) or high molecular weight (HMW) barley beta-glucan (from Cargill) twice daily, in cereal and juice.
Post treatment assessment of blood lipids and other CVD biomarkers revealed improvements in low-density lipoprotein (LDL) cholesterol, triglycerides, markers of glycemic control (glycosylated hemoglobin, HOMA model) and a key marker of inflammation (hs-CRP).
The researchers concluded both doses of LMW and HMW barley beta-glucan improved blood lipids over a six-week treatment period.
Related posts:
Visitor Guidance :::MOUSE OVER YOUR POINTER TO THE HOMEOPATHIC AND NATURAL IMAGE PRODUCTS FOR SHORT PRODUCTS DESCRIPTION (YOUR JAVASCRIPT BROWSER MUST BE ENABLE) OR SEE IN ABOVE SUB-CATEGORIES::: Return to HOMEPAGE.

forex robot said on Monday, November 30, 2009, 10:29
great post as usual .. thanks .. you just gave me a few more ideas to play with
Valentin Jurcik said on Wednesday, January 20, 2010, 10:39
I usually don??t post in Blogs but your blog forced me to, amazing work.. beautiful ??